Using a digital tool to help patients understand cancer treatment plans
Part of Cancer, Kidney & urinary clinical trials.
This study tests a digital tool called MyCareGorithm that helps patients understand their cancer treatment plans. It is for people with head and neck or prostate cancer, their caregivers, and their doctors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with head and neck or prostate cancer.
- You are receiving treatment at MD Anderson Cancer Center.
- You can speak and understand English.
- You are a caregiver or a doctor/nurse practitioner involved in the care of such patients.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an English decision aid (a patient guide) to help older men understand and feel comfortable with “active surveillance” for localized prostate cancer. It also checks how easy to use it is for patients, caregivers, and prostate cancer clinicians.
This trial uses a digital assessment tool to track symptoms and side effects in patients with head and neck cancer who are getting radiation therapy (with or without chemotherapy). The goal is to see if it helps improve care in both rural and urban areas.
This study tests a new care tool for people with gynecologic, prostate, lung, or colorectal cancer. It helps your care team (doctors, nurses, social workers) and patients like you see if the tool improves support and communication.
This study tests a digital support tool that helps you understand your prostate cancer diagnosis and treatment options. It uses artificial intelligence to guide you through educational materials and connect you with support resources.
This trial tests a computer tool that analyzes your conversations with doctors. It aims to help you make a more informed choice about prostate cancer treatment.
This trial tests an English computer tool that gives feedback during prostate cancer treatment visits. It aims to help you and your clinician make more informed, shared decisions about next treatment steps.
Hear when a new Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.